GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SkinBioTherapeutics PLC (LSE:SBTX) » Definitions » Insider Ownership

SkinBioTherapeutics (LSE:SBTX) Insider Ownership : 3.42 % (As of Jun. 14, 2024)


View and export this data going back to 2017. Start your Free Trial

What is SkinBioTherapeutics Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, SkinBioTherapeutics's insider ownership is 3.42%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, SkinBioTherapeutics's Institutional Ownership is 3.94%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, SkinBioTherapeutics's Float Percentage Of Total Shares Outstanding is 0.00%.


SkinBioTherapeutics Insider Ownership Historical Data

The historical data trend for SkinBioTherapeutics's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SkinBioTherapeutics Insider Ownership Chart

SkinBioTherapeutics Historical Data

The historical data trend for SkinBioTherapeutics can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Insider Ownership 3.94 3.94 3.94 3.58 3.63 3.63 3.61 3.59 3.45 3.42

SkinBioTherapeutics Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.


SkinBioTherapeutics (LSE:SBTX) Business Description

Traded in Other Exchanges
N/A
Address
Bath Lane, The Core, Newcastle Helix, Newcastle upon Tyne, GBR, NE4 5TF
SkinBioTherapeutics PLC is a life science company focused on skin health. It is focused on the development of technology to protect, manage, and restore skin utilizing proteins found in the human microbiota. It is targeting three specific skin healthcare sectors; cosmetics, infection control, and eczema.

SkinBioTherapeutics (LSE:SBTX) Headlines

From GuruFocus